EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy of preventive antiarrhythmic therapy in patients with paroxysmal atrial fibrillation (AF).Material and methods. 40 patients with paroxysmal AF were involved in open-label, cross-over study with periods of antia...
Saved in:
Main Authors: | L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-12-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/545 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01) -
Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01) -
THE PROPANORM EFFICACY IN RAPID RELIEF OF SYMPTOMS OF PAROXYSMAL AURICULAR FIBRILLATION
by: N. N. Borovkov, et al.
Published: (2003-10-01) -
Hearing the Vagus Nerve’s Rhythm in Patients with Paroxysmal Atrial Fibrillation
by: A. A. Nechepurenko, et al.
Published: (2020-07-01) -
Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter
by: D. A. Gagloeva, et al.
Published: (2023-05-01)